- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04112121
Psychological, Neurological and Immunological Changes Following a Meeting With a Chaplain Coupled With Biblical Readings (HEALING)
October 11, 2019 updated by: Dr. András Béres, Somogy Megyei Kaposi Mór Teaching Hospital
Hospital-based Ecumenical And Linguistical, Immuno- Neuro-Genetic (HEALING) Study - Randomized Clinical Trial - A Study on the Epigenetic Background of Neuro-immune-modulation in Clinical Environment
The aim of the "HEALING" " (Hospital-based Ecumenical And Linguistic Immuno-NeuroloGic) Study was to examine immunological and neurological changes in hospitalized participants after meeting a chaplain and Biblical listenings, in order to evaluate whether these meetings affect the course of the disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The authors pre-screened hospitalized participants to find those who were the most in need of an intervention by a chaplain.
A passage from the Bible was read to the participants during a meeting with the chaplain at the bedside, or in the chapel of the hospital.
No meeting occurred in the randomized control group, which was compiled in a way to get a group of participants with an approximatively similar pattern of diagnoses and treatment days than the intervention groups.
The pace of enrollment was deliberately slow in order to assure the authenticity of the visits ("slow science").
Blood samples were taken 30 minutes prior, and 60 minutes after the meeting to measure White Blood Cell (WBC)-, lymphocyte counts, interferon gamma (IFN-γ)-, immunoglobulin M (IgM)-, immunoglobulin A (IgA)-, immunoglobulin G (IgG)-, and complement C3 levels.
A subgroup of the visited participants was subjected to functional Magnetic Resonance Imaging (fMRI), where they were played an audiotape of readings of the same passage from the Bible.
Associative tests, paired-samples t-test, network analysis was performed to search for any correlation between psychological and immunological parameters, completed with Statistical Parametric Mapping to search for correlations of the above with neurological parameters.
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kaposvár, Hungary, 7400
- Somogy Megyei Kaposi Mór Teaching Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult age (>18 years)
- the condition of being hospitalized
- the ability for verbal communication
- alertness, orientation
- no sign of psychosis in their medical history
- willingness to participate in the study after written, informed consent
Exclusion Criteria:
- the inability to communicate verbally
- psychotic state, altered mental state
- unwillingness to participate
- active and treated malignant disease
- steroid, NSAID or metamizole- sodium use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients Meeting the Chaplain at the Bedside
First meeting with the chaplain, coupled with biblical readings at the bedside.
|
|
|
Experimental: Patients Meeting the Chaplain at the Chapel
First meeting with the chaplain, coupled with biblical readings at the hospital's chapel
|
|
|
No Intervention: Patients Not Meeting the Chaplain
In the control group we enrolled patients whose diagnoses and number of days in the hospital was similar to the intervention groups (covariate-adaptive, blocked, stratified randomization method).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in lymphocyte count
Time Frame: Change from baseline at 120 minutes
|
lymphocyte count measured with automatised laboratory measurement and microscopic blood smear examination
|
Change from baseline at 120 minutes
|
|
Change in total white blood cell (WBC) count
Time Frame: Change from baseline at 120 minutes
|
WBC count measured with automatised laboratory measurement and microscopic blood smear examination
|
Change from baseline at 120 minutes
|
|
Change in interferon-gamma level
Time Frame: Change from baseline at 120 minutes
|
enzyme-linked immunosorbent assay
|
Change from baseline at 120 minutes
|
|
Change in immunoglobulin M level
Time Frame: Change from baseline at 120 minutes
|
enzyme-linked immunosorbent assay
|
Change from baseline at 120 minutes
|
|
Change in immunoglobulin A level
Time Frame: Change from baseline at 120 minutes
|
enzyme-linked immunosorbent assay
|
Change from baseline at 120 minutes
|
|
Change in immunoglobulin G level
Time Frame: Change from baseline at 120 minutes
|
enzyme-linked immunosorbent assay
|
Change from baseline at 120 minutes
|
|
Change in complement C3 level
Time Frame: Change from baseline at 120 minutes
|
enzyme-linked immunosorbent assay
|
Change from baseline at 120 minutes
|
|
Change in functional Magnetic Resonance Imaging activity
Time Frame: Change from baseline during the 60 second long activation block
|
Statistical Parametric Mapping analysis of Blood Oxygenation Level Dependent (BOLD) answers
|
Change from baseline during the 60 second long activation block
|
|
Participants' satisfaction with the visit as assessed by Scores given on the "Healing - after" Questionnaire
Time Frame: within 1 hour after intervention
|
Participants' assessement of their satisfaction on single-item rating scales in a Questionnaire designed for the Study.
Answers range from 1 to 5, with higher values representing better outcomes.
|
within 1 hour after intervention
|
|
Chaplain's satisfaction with the visit as assessed by Scores given on the "Healing - after" Questionnaire
Time Frame: within 1 hour after intervention
|
Chaplain's assessement of her satisfaction on single-item rating scales in a Questionnaire designed for the Study.
Answers range from 1 to 5, with higher values representing better outcomes.
|
within 1 hour after intervention
|
|
Participants' level of distress in the month preceding the measurement as assessed with the total Score of the Perceived Stress Scale 14 (PSS-14)
Time Frame: within 30 minutes before intervention
|
PSS-14 Scale uses 14 questions with answers ranging from 0 to 4, with higher values indicating higher levels of distress on the seven negative-, and lower levels of distress on the seven positive items.
Scores are obtained by reversing the scores on the seven positive items, then summing across all to give the total PSS-14 Score.
|
within 30 minutes before intervention
|
|
Participants' spiritual and psychological needs, religious practice, thoughts about how they became sick, and how they could heal, as assessed by Scores given on the "Healing - before" Questionnaire
Time Frame: within 30 minutes before intervention
|
Participants' assessement on single-item rating scales in a Questionnaire designed for the Study ("Healing - before" Questionnaire).
Answers range from 1 to 5, with higher values representing better outcomes.
|
within 30 minutes before intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: András Béres, M.D., Physician
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 10, 2015
Primary Completion (Actual)
January 2, 2017
Study Completion (Actual)
January 2, 2017
Study Registration Dates
First Submitted
September 29, 2019
First Submitted That Met QC Criteria
September 30, 2019
First Posted (Actual)
October 2, 2019
Study Record Updates
Last Update Posted (Actual)
October 15, 2019
Last Update Submitted That Met QC Criteria
October 11, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- HEALING STUDY IG/3355/2013
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hospitalism
-
GCS Ramsay Santé pour l'Enseignement et la RechercheEuraxi PharmaRecruiting
-
Massachusetts General HospitalCompleted
-
The University of Texas Health Science Center,...WithdrawnHospitalism in ChildrenUnited States
-
University of PennsylvaniaCompletedHospitalismUnited States
-
Hacettepe UniversityCompleted
-
University of Colorado, DenverJohns Hopkins University; Denver Health and Hospital AuthorityCompleted
-
Ataturk UniversityRecruitingFear | Child, Only | Hospitalism in ChildrenTurkey (Türkiye)
-
Karamanoğlu Mehmetbey UniversityRecruitingHospitalism in ChildrenTurkey
-
Tabula Rasa HealthCareTerminated
-
Universitair Ziekenhuis BrusselBaxter Healthcare CorporationCompleted
Clinical Trials on Meeting with a Chaplain coupled with Biblical Readings
-
Minnesota Department of HealthCompletedBreast Cancer | Colorectal CancerUnited States
-
AdministrateurCICPRAXIM companyCompletedSurgical Procedure, UnspecifiedFrance
-
Centre Francois BaclesseLigue contre le cancer, FranceActive, not recruitingLong Term Cancer Side Effects | Supportive Care in Cancer | Cancer Survivorship Care Plan | Advanced Nurse Practitioner | Pelvic Gynecological CancerFrance
-
Tanta UniversityRecruitingEndodontic Disease | Irrigation ActivationEgypt
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Israel